Novel Pharmacodynamic Approach to Assess Obatoclax (GX15-070) and Bortezomib (BTZ) Synergism in Non-Hodgkin’s Lymphoma

Publisher： Bentham Science Publishers

ISSN： 2212-697X

Source： Clinical Cancer Drugs, Vol.2, Iss.1, 2015-05, pp. : 44-53

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel treatment strategies for aggressive non-Hodgkin’s lymphoma

By Fayad Luis   Younes Anas  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 6, 2006-04 ,pp. : 733-748

Informa Healthcare

Access to resources Recommend Favorite

Treatment advances in non-Hodgkin’s lymphoma

By Tan B.R.   Bartlett N.L.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 3, 2000-03 ,pp. : 451-465

Informa Healthcare

Access to resources Recommend Favorite

Economic assessment in the management of non-Hodgkin’s lymphoma

By van Agthoven Michel   Uyl-de Groot Carin A   Sonneveld Pieter   Hagenbeek Anton  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 12, 2004-12 ,pp. : 2529-2548

Informa Healthcare

Access to resources Recommend Favorite

The role of pixantrone in the treatment of non-Hodgkin’s lymphoma

By Borchmann Peter  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 8, 2005-08 ,pp. : 1055-1061

Informa Healthcare

Access to resources Recommend Favorite

Gallium nitrate for the treatment of non-Hodgkin’s lymphoma

By Chitambar Christopher R  

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 5, 2004-05 ,pp. : 531-541

Informa Healthcare

Access to resources Recommend Favorite